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Background: The present investigation was aimed at evaluating the hypoglycemic and hypolipidemic properties of
the aqueous and methanolic extracts from Bersama engleriana leaves in streptozotocin/nicotinamide
(STZ-NA)-induced type 2 diabetic rats.
Methods: Animals were orally treated for 4 consecutive weeks with Bersama engleriana extracts at doses of 300 or
600 mg/kg. The anti-diabetic effect was examined by measuring blood glucose (BG) at 0, 1, 14 and 28 days after
STZ-NA treatment and, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein
cholesterol (LDL-C) and triglycerides (TG) levels at sacrifice (day 29). Glibenclamide (0.25 mg/kg) was used for
comparison.
Results: STZ-NA-induced diabetic rats showed moderate to significant increases in the levels of BG, TG, TC, LDL-C
while body weight, HDL-C levels and relative weights of liver and pancreas were decreased compared to controls
(non diabetic rats). Administration of the plant extracts to STZ-NA diabetic rats resulted in a significant decrease in
BG, TG, TC and LDL-C and the dose 600 mg/kg of the methanolic extract was the most effective; HDL-C level was
markedly increased after four weeks compared to untreated diabetic rats. A dose-dependent increase in the relative
weights of the diabetogenic organs was observed in the Bersama engleriana groups. It can be also noticed that the
methanolic extract, especially the dose 600 mg/kg (p<0.001), produced more effects than glibenclamide and
aqueous extract. Rats treated with glibenclamide (0.25 mg/kg) generally gave lower results compared to groups
treated with plant extracts.
Conclusion: Results of the present study showed that Bersama engleriana extracts and especially its methanolic
extract possess antidiabetogenic properties and beneficial effects on diabetic hyperlipidemia. All these effects could
be due to the bioactive components revealed in the Bersama engleriana extracts such as triterpenes and phenols
and which could justify its ethnomedical use.
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Type 2 diabetes is caused by the failure of beta cells to
compensate for insulin resistance. This leads to hypergly-
caemia, which can in turn exert deleterious effects on β
cells [1]. Evidence for the importance of plant extracts in
the management of type 2 diabetes is emerging. Medicinal
plants are frequently considered to be less toxic and free
from side effects than synthetic ones. Bersama engleriana
Gurke (Melianthaceae) is one of such plants; it is a small
or medium size tree of 6-9 m, rarely exceeding 25 m in
height. It is widespread throughout tropical Africa, prefer-
ring higher rainfall or evergreen forests. It is distributed
from Senegal to Zaire, and parts of southern Africa; the
leaves are used for the treatment of many ailments includ-
ing diabetes and male impotence [2].
Previous findings have exhibited a variety of pharmaco-
logical potentials including blood glucose lowering con-
centration in oral glucose tolerance test [3], aphrodisiac
[4], non-toxic, anti-tumor, antioxidant and antimicrobial
[5] and, ejaculation delaying (unpublished data) activities.
The present work was undertaken to investigate the anti-
diabetic effects of aqueous and methanol extracts from
the leaves of Bersama engleriana in a non-obese diabetes
model characterized by reduced pancreatic insulin con-
tents and moderate hyperglycemic levels, like those usu-
ally occurring in human type 2 diabetes. This model,
obtained by the combined administration of nicotinamide
(NA) and streptozotocin (STZ) is increasingly used for
pharmacological research in diabetes [6-9].
Methods
Collection of plant material and extraction
The leaves of Bersama engleriana (Melianthaceae) were
collected in the Bamboutos mountains, west region of
Cameroon. Botanical identification was carried out at the
National Herbarium, Yaoundé, Cameroon (HNC) where a
voucher specimen No. 32427/HNC has been deposited.
The leaves were shade-dried and reduced to powder.
Aqueous extract
A total of 400 g of the powder of Bersama engleriana
leaves were extracted in 5 l of distilled water for 1 h and
boiled for 30 min. The heated decoction was taken and
allowed to cool at room temperature (22 ± 2°C). The de-
coction was filtered and the filtrate was oven dried (45°C).
The resulting material was found to weigh 112 g (28%
yield, w/w based on the dried starting weight). The work-
ing solution was obtained by dissolving 1 g of the residue
in a known volume of distilled water and the final volume
adjusted to 10 mL.
Methanolic extract
Ground leaves (600 g) of Bersama engleriana were mace-
rated with methanol (3 L; 2 × ) for 72 h to yield, aftersolvent evaporation under reduced pressure, 16.5 g of
brownish extract corresponding to an extraction yield of
14.29% (w/w based on the dried starting weight). The
working methanolic extract was obtained by dissolving 1 g
of the residue in a known volume of distilled water and
the final volume adjusted to 10 mL.
Preliminary phytochemical screening
Qualitative phytochemical evaluation was performed
on aqueous and methanolic extracts of the leaves of
B. engleriana to determine the presence or not of flavo-
noids (test of Shinoda), sterols (Libermann Buchard test),
phenols (ferric chloride test), alkaloids (Dragendorff test),
saponins (saponification test) all these tests were per-
formed as described by [10].
Animals
Adult male Wistar rats weighing 200-300 g were used in
this study. The animals were maintained at room
temperature (22-23°C) with a reverse natural light-dark
cycle in the animal house of the Faculty of Science, Uni-
versity of Dschang, Cameroon. Food and tap water were
available ad libitum. The experiments were performed
in accordance with the internationally accepted standard
ethical guidelines for laboratory animal use and care as
described in the European Community guidelines; EEC
Directive 86/609/EEC, of the 24th November 1986 [11].
Induction of diabetes
Nicotinamide (95 mg/kg b.w.) (Sigma, Saint-Louis, MO,
USA), dissolved in saline, was injected intraperitoneally
15 min before administration of STZ (60 mg/kg b. w.)
(Sigma, Saint-Louis, MO, USA), which was dissolved in
buffer citrate (pH 4.5) immediately before use. After
1 week, rats with moderate diabetes having hypergly-
cemia with blood glucose ≥ 126 mg/dl were used for the
study [12]. Blood was collected from the tail vein. Con-
trols received both vehicles.
Experimental design
In the experiment, a total of 42 rats (36 diabetic rats + 6
normal rats) were used. Diabetes was induced in rats,
2 weeks before starting the treatment. The animals were
divided into seven groups containing six rats each and
distributed as follows:
Group 1, control rats given distilled water (10 ml/kg b.
w.); Group 2, diabetic rats given distilled water (10 ml/kg b.
w.); Group 3, diabetic rats given glibenclamide (0.25 mg/kg
b.w.); Group 4, diabetic rats given aqueous extract of Ber-
sama engleriana (300 mg/kg b.w.); Group 5, diabetic rats
given aqueous extract of Bersama engleriana (600 mg/kg b.
w.); Group 6, diabetic rats given methanolic extract of
Bersama engleriana (300 mg/kg b.w.); Group 7, diabetic
rats given methanolic extract of Bersama engleriana
Watcho et al. BMC Complementary and Alternative Medicine 2012, 12:264 Page 3 of 6
http://www.biomedcentral.com/1472-6882/12/264(600 mg/kg b.w.). All test substances were administered by
gastric gavage for 4 weeks. Glycaemia was measured 0, 1,
2, and 4 weeks after pharmacological treatments. Body
weight and relative weights of pancreas and liver were
recorded. All the seven groups of rats were killed one day
after the last treatment (day 29) by cervical dislocation.
Blood was collected for total cholesterol (TC), HDL-
cholesterol (HDL-C), LDL-cholesterol (LDL-C), and tri-
glycerides (TG) estimations using commercial kits from
INMESCO (Germany).
Statistical analysis
Data are expressed in mean ± SEM due to the non
homogeneity of groups. The effect of the duration of the
treatment (week 0 to week 4) on blood glucose concen-
tration was analyzed using ANOVA Repeated Measures
followed by Bonferroni test when necessary. For other
parameters, One-way analysis of variance (ANOVA) fol-
lowed by post-hoc Bonferroni was performed using SPSS
for Windows version 12.0. Comparisons with p values
< 0.05 were considered to be statistically significant.
Results
Phytochemical analysis
Qualitative phytochemical screening of the aqueous and
methanolic extracts of the leaves of Bersama engleriana
showed sterols, triterpens and saponins (Table 1).
Effects of Bersama engleriana on body weight and
relative organ weights
Induction of diabetes (untreated diabetic rats) signifi-
cantly (p<0.01) decreased the body weight compared to
controls.
Oral treatment of diabetic animals with glibenclamide
(0.25 mg/kg) or methanolic extract of Bersama engleriana
significantly (p<0.05 - 0.01) improved the body weight
during the entire period of treatment. This increase was
more expressed in rats receiving the highest dose
(600 mg/kg) of the methanolic extract (19.05%). On the
contrary, aqueous extract of Bersama engleriana (300 and
600 mg/kg) did not show any improvement in the body
weight (Table 2).Table 1 Results of the phytochemical screening of
Bersama engleriana extracts
Group of compounds Aqueous extract Methanolic extract
Flavonoids - -
Sterols + +
Phenolic compounds - -
Alkaloids - -
Saponins + +
+: present - : absent.The relative weights of pancreas and liver were also
decreased in all diabetic animals when compared to con-
trols. However with regard to diabetic animals, a dose-
dependent increase in the relative weights of these vital
organs was observed in the Bersama engleriana groups. It
can be also noticed that the methanolic extract, especially
the dose 600 mg/kg, produced more effects (p<0.001) than
glibenclamide and aqueous extract (Table 2).Effects of Bersama engleriana on blood glucose
Table 3 shows the effects of aqueous and methanol
extracts of the leaves of Bersama engleriana on blood
glucose levels of Wistar rats after 4 weeks of continuous
treatment. Sequential injections of nicotinamide and
streptozotocin caused a significant increase (p <0.05 to
0.001) in blood glucose concentrations in all groups of
rats compared with their respective baseline blood glu-
cose (at the time of grouping) and to control values. At
all-time points, blood glucose concentrations remained
unchanged (p>0.05) in normal rats treated with distilled
water. However, oral administration of the plant extracts
as well as glibenclamide to diabetic rats provoked a
week-dependent decrease (p<0.05 to 0.001) in blood glu-
cose concentrations. Thus after 4 weeks of continuous
treatment, the dose 600 mg/kg of the methanolic extract
of Bersama engleriana produced the most alleviating
effects (80.31%) compared to aqueous extract (600 mg/kg;
67.74%) and glibenclamide (58.65%). At equal dose, the
methanolic extract was more efficient than the aqueous
extract.Effects of Bersama engleriana on lipid profile
The diabetic condition in rats (untreated diabetics)
raised TC (36.13%), LDL-C (61.82%) and TG (14.20%)
concentrations and lowered HDL-C level (65.59%)
(p<0.05) compared to control rats (non diabetic rats).
Treatment of nicotinamide/streptozotocin-induced dia-
betic animals with Bersama engleriana extracts and es-
pecially the methanolic extract produced opposite effects
evidenced by a decrease (p<0.05) in serum TC (percent-
age of decrease: 300 mg/kg, 19.68%; 600 mg/kg, 34.38%)
and LDL-C (percentage of decrease: 300 mg/kg, 24.70%;
600 mg/kg, 50.19%) and an increase in the HDL-C
(percentage of increase: 300 mg/kg, 58.48%; 600 mg/kg,
62.27%) concentration when compared to untreated
diabetic. A tendency to a decrease in TG concentrations
was also observed with regard to diabetic rats receiving
distilled water. In general, glibenclamide produced simi-
lar effects.
As above observed, the methanolic extract appeared to
be more efficient than the aqueous extract at equal dose
and, more potent at high dose (600 mg/kg) than gliben-
clamide (Table 3).
Table 2 Effects of Bersama engleriana on body weight, relative weights of liver and pancreas and, lipid profile on
nicotinamide/streptozotocin-induced diabetic rats
































































































































Values are means ± SEM; number of animals per group = 6.
*: p<0.05; *** p <0.001: significantly different compared to control.
#: p <0.05; ##: p <0.01; ###: p<0.001 significantly different compared to untreated diabetic.
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Association of nicotinamide and streptozotocin is being
increasingly used for inducing a diabetes mellitus (DM)
similar to human’s type 2 DM [6-9]. In this sequential
combination, nicotinamide protects pancreatic beta cells,
delaying their disappearance, improves their regeneration
and controls blood glucose parameters [13] whereas strep-
tozotocin has toxic effect resulting in increased formation
of free radicals that alter the plasma membrane of β cells
and fragmented DNA [14]. The moderate hyperglycemic
state (≥126 mg/dl) recorded in rats throughout the presentTable 3 Effects of Bersama engleriana on blood glucose in nic
Groups
At the time of
grouping
Week
Control 97.80 ± 02.97 69.00 ± 0
Untreated diabetic 97.40 ± 04.54 270.80 ± 8
Diabetic + Glibenclamide (0.25 mg/kg) 86.40 ± 06.53 227.80 ± 8
Diabetic + Aqueous extract (300 mg/kg) 95.40 ± 05.08 156.60 ± 2
Diabetic + Aqueous extract (600 mg/kg) 91.00 ± 06.47 303.80 ± 4
Diabetic + Methanolic extract (300 mg/kg) 90.20 ± 04.18 181.80 ±
Diabetic + Methanolic extract (600 mg/kg) 90.20 ± 03.38 454.00 ± 10
Values are means ± SEM; number of animals per group = 6.
On the same line, values assigned with the same letter are not significantly differen
Within a column, *: p<0.05; **: p <0.01; *** p <0.001: significantly different compare
#: p <0.05; ###: p <0.001: significantly different compared to untreated diabetic.experiment confirms the real diabetic status of the animals
used in the present study.
In type 2 diabetic rats treated with Bersama engleriana
extracts, a significant decrease (p<0.05) in blood glucose
concentrations was observed when compared to respect-
ive baseline values (week 0). These results further support
the hypoglycemic activity of Bersama engleriana previ-
ously reported in sugar overloaded normal rats [3]. It is
generally believed that most of the medicinal plants with
antidiabetic potentials have been found to contain a var-
iety of substances responsible for the reported activitiesotinamide/streptozotocin-induced type 2 diabetic rats
Fasting blood glucose level (mg/dl)
Week of treatment
0 Week 1 Week 2 Week 4
7.40a 75.8 ± 09.05a 81.00 ± 04.25a 62.00 ± 03.45a
1.14a*** 244.40 ± 69.28a*** 202.60 ± 55.54a* 203.00 ± 46.62a**
3.62a** 146.40 ± 51.05ad 98.20 ± 09.28bd 94.20 ± 11.20bd
0.76#a 121.80 ± 06.80#a 109.60 ± 07.15a 96.60 ± 02.67a
1.86a*** 183.60 ± 33.96bd 119.00 ± 04.63cd 98.00 ± 07.52c
48.41a* 114.00 ± 15.71#a 86.60 ± 07.35#a 83.60 ± 08.18#a
.93a*** ### 288.40 ± 45.75b*** 167.60 ± 42.28c 89.40 ± 06.23#c
t.
d to control.
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triterpenes, steroids, saponins and phenolic compounds in
Bersama engleriana extracts. It has been demonstrated
that triterpenes and phenols stimulate insulin secretion
through their antioxidant activities [16,17]. Oxidative
stress has been shown to play a key role in the causation
of diabetes. Streptozotocin produces oxygen radicals in
the body, which cause pancreatic injury and could be re-
sponsible for increased blood sugar as well as lipid peroxi-
dation. As such, antioxidants may have a role in the
alleviation of diabetes [18]. From the results obtained in
this work, it could be proposed that Bersama engleriana
may enhance the antioxidant defense against reactive oxy-
gen species produced under hyperglycemic condition and
this could protect beta-cells against loss, and exhibit anti-
diabetic activity. The in vitro antioxidant property of
Bersama engleriana previously reported by [5] using
extracts from the roots, stem bark, leaves and wood of this
medicinal plant could be of great importance in the under-
standing of this suggested in vivo antioxidant activity of
Bersama engleriana. It is a well-established fact that many
medicinal plants possess antioxidant potentials which
might be helpful under diabetic conditions [19-21]. Results
from this work also indicate that the methanolic extract,
especially the dose 600 mg/kg, produced more alleviating
effects. This observation confirms the fact that methanol
extracts of plants are generally known for their high con-
tents in chemical compounds capable of producing bio-
logical activities [22].
With regard to the lowering blood glucose concentra-
tions, it could be proposed that Bersama engleriana may
act by (1) stimulating insulin secretion similarly to gliben-
clamide [23], (2) triggering progressive regeneration of the
damaged β cells after sequential injection of nicotinamide
and streptozotocin or (3) potentiating glucose uptake and
use by various tissues [17,24,25]. The improvements
observed in the body weight as well as in the relative
weights of the pancreas and liver of diabetic animals after
plant extract applications further support these proposed
pancreatic and extra-pancreatic mechanisms of action of
Bersama engleriana [26-29].
As one of the complications that followed diabetic
hyperglycemia is dyslipidemia, the serum lipid profile of
rats was evaluated in this study. As expected, untreated
diabetic animals showed a significant increase in serum
TC, LDL-C and TG concentrations against low levels of
HDL-C [27,30,31]. This increase in serum lipids is
mainly due to the increased fatty acid mobilization from
adipose tissue. Since insulin has an inhibitory action on
HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl co-
enzyme A reductase), the key enzyme in cholesterol bio-
synthesis [32], insulin deficiency or insulin resistance
may therefore be responsible for hyperlipidemia. Treat-
ment of type 2 diabetic rats with Bersama englerianaextracts, especially its methanolic extract (600 mg/kg),
reversed although not completely dyslipidemia as evi-
denced by the significant decrease (p<0.05) in TC, LDL-
C and TG coupled to the increase in HDL-C (p <0.05).
These alleviating effects clearly denote the antihyperlipi-
demic potential of Bersama engleriana [33], and may
also account in the improvement of liver weight as above
observed. It could also be suggested that this antihyperli-
pidemic effects of Bersama engleriana pass through a
decrease in intestinal cholesterol absorption or a de-
crease in the biosynthesis of cholesterol specifically by
decreasing the activity of HMG-CoA reductase inhibi-
tors [34].
Conclusions
From this study, we can conclusively state that, Bersama
engleriana extract and especially the methanolic extract
possesses antidiabetogenic properties and beneficial
effects on diabetic hyperlipidemia. All these beneficial
effects on this rat model could be due to the bioactive
components revealed in the Bersama engleriana extracts
such as triterpenes and phenols.
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